Bio Medical Beauty Group UltraV (CEO Hanjin Kwon) announced on the 30th that PDO MICROSPHERE 'UltraCol', which was certified for the first time in the world with its independent technology, has obtained Kuwait product approval.

It is planning to increase the local market control of its local market mastery.

​Kuwait has established itself in daily life to the extent that cosmetic treatments are common for women due to the influence of social media (SNS) and media, and the demand for cosmetic treatments, regardless of gender, is expected to increase further as men's appearance is also recognized as competitive in recent competitive social life.

​Therefore, it is expected to gradually expand to neighboring countries and increase brand awareness starting with the acquisition of Kuwait's license. In addition, interest in improving quality of life is increasing due to the rapid aging phenomenon in Middle Eastern countries, which is expected to lead to the growth of the beauty medical market.

​"Kuwait is a country that has a great influence on the Asian beauty and medical industry," an UltraV official said. "It is not only meaningful in that it has obtained Kuwait's license, but it is also expected to accelerate its market share in Asia."

​UltraCol is a self-collagen dermabooster product released in Korea by UltraV. It was the only polymer filler in Asia that won the IR52 Jang Young-sil Award, and its efficacy, biodegradability and stability in the human body were proven, and it obtained the Korean Food and Drug Administration (KFDA) and Europe CE certification.

Recently, as the COVID-19 issue has ended and overseas product permits have been actively carried out again, the export road has been opened, and since then, product permits have been smoothly carried out.

UltraV said, "UltraCol has received product licenses not only in Kuwait but also in Hong Kong, Italy, and Ecuador this year, and we will also focus on building production lines accordingly as production of products increases when all sales registrations in Asian and European countries are completed."

Meanwhile, "UltraCol" is expanding its global business by acquiring licenses and certifying sales licenses in many countries, including obtaining product licenses from the Thai Food and Drug Administration (TFDA), and it is expected that good news will soon be delivered in the Chinese market, which has a high threshold for entry, so it is expected that it will soon be able to enter the top ranks of the industry not only at domestic but also abroad.

​

​

​

​